Jin Tae Hong Selected Research

Bee Venoms (Bee Venom)

2/2020	Anti-inflammatory effect of bee venom in phthalic anhydride-induced atopic dermatitis animal model.
1/2019	Bee Venom Soluble Phospholipase A2 Exerts Neuroprotective Effects in a Lipopolysaccharide-Induced Mouse Model of Alzheimer's Disease via Inhibition of Nuclear Factor-Kappa B.
1/2019	Bee venom phospholipase A2 ameliorates amyloidogenesis and neuroinflammation through inhibition of signal transducer and activator of transcription-3 pathway in Tg2576 mice.
12/2015	Anti-cancer effect of bee venom on colon cancer cell growth by activation of death receptors and inhibition of nuclear factor kappa B.
6/2015	Bee venom ameliorates lipopolysaccharide-induced memory loss by preventing NF-kappaB pathway.
3/2015	Bee venom inhibits growth of human cervical tumors in mice.
7/2014	Cancer cell growth inhibitory effect of bee venom via increase of death receptor 3 expression and inactivation of NF-kappa B in NSCLC cells.
3/2014	Co-culture with NK-92MI cells enhanced the anti-cancer effect of bee venom on NSCLC cells by inactivation of NF-κB.
1/2012	Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway.
6/2011	Anti-cancer effect of bee venom in prostate cancer cells through activation of caspase pathway via inactivation of NF-κB.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jin Tae Hong Research Topics

Disease

121	Neoplasms (Cancer) 01/2022 - 12/2002
52	Inflammation (Inflammations) 01/2022 - 11/2004
44	Alzheimer Disease (Alzheimer's Disease) 12/2021 - 05/2004
35	Neuroinflammatory Diseases 01/2022 - 01/2009
22	Colonic Neoplasms (Colon Cancer) 10/2017 - 02/2003
16	Lung Neoplasms (Lung Cancer) 01/2022 - 11/2012
15	Constipation 01/2022 - 11/2013
15	Cognitive Dysfunction 01/2020 - 08/2008
12	Melanoma (Melanoma, Malignant) 06/2019 - 01/2012
11	Atopic Dermatitis (Atopic Eczema) 12/2020 - 07/2013
10	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2008
10	Arthritis (Polyarthritis) 11/2016 - 11/2004
9	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2020 - 01/2012
8	Memory Disorders (Memory Loss) 01/2020 - 01/2012
8	Carcinogenesis 01/2020 - 12/2002
7	Obesity 12/2020 - 09/2012
6	Parkinson Disease (Parkinson's Disease) 01/2022 - 08/2015
6	Hyperplasia 11/2018 - 09/2007
6	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2017 - 03/2009
6	Prostatic Neoplasms (Prostate Cancer) 08/2011 - 02/2007
5	Necrosis 02/2015 - 07/2010
5	Edema (Dropsy) 05/2014 - 11/2004
4	Amyloid Plaque 07/2021 - 02/2012
4	Stroke (Strokes) 03/2020 - 07/2009
4	Hypoxia (Hypoxemia) 01/2020 - 08/2013
4	Breast Neoplasms (Breast Cancer) 01/2019 - 08/2007
4	Infections 12/2018 - 07/2011
4	Atherosclerosis 01/2018 - 06/2008

Drug/Important Bio-Agent (IBA)

42	Proteins (Proteins, Gene)FDA Link 07/2021 - 10/2007
38	CytokinesIBA 01/2022 - 03/2009
38	NF-kappa B (NF-kB)IBA 01/2020 - 11/2004
22	LipopolysaccharidesIBA 12/2020 - 08/2008
19	Amyloid (Amyloid Fibrils)IBA 12/2021 - 01/2011
17	Pharmaceutical PreparationsIBA 10/2021 - 10/2007
17	Amyloid beta-PeptidesIBA 08/2018 - 05/2004
15	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 10/2007
14	Ethanol (Ethyl Alcohol)IBA 01/2020 - 07/2009
13	AntioxidantsIBA 01/2021 - 10/2007
13	Bee Venoms (Bee Venom)IBA 02/2020 - 11/2004
12	Peptides (Polypeptides)IBA 12/2021 - 05/2004
12	Small Interfering RNA (siRNA)IBA 10/2018 - 10/2010
12	Death Domain ReceptorsIBA 07/2017 - 01/2012
11	Loperamide (Imodium)FDA LinkGeneric 01/2022 - 11/2013
11	phthalic anhydrideIBA 12/2020 - 04/2011
11	thiacremononeIBA 07/2016 - 08/2007
10	LaxativesIBA 01/2021 - 11/2013
10	Peroxiredoxin VIIBA 01/2020 - 12/2013
10	4-O-methylhonokiolIBA 07/2015 - 07/2009
9	Caspase 3 (Caspase-3)IBA 01/2021 - 01/2012
9	Therapeutic UsesIBA 03/2020 - 07/2013
9	Transcription Factors (Transcription Factor)IBA 03/2016 - 08/2007
8	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 07/2021 - 01/2009
8	Snake Venoms (Snake Venom)IBA 02/2016 - 02/2007
7	LigandsIBA 01/2022 - 11/2003
7	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2022 - 12/2002
7	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 06/2012
7	magnesium monoperoxyphthalateIBA 05/2019 - 11/2016
7	CC ChemokinesIBA 01/2019 - 01/2012
7	Docetaxel (Taxotere)FDA Link 07/2014 - 05/2009
7	obovatolIBA 07/2012 - 03/2008
6	ChitinasesIBA 01/2022 - 01/2018
6	Interleukin-4 (Interleukin 4)IBA 12/2020 - 04/2011
6	Neuroprotective AgentsIBA 03/2020 - 05/2012
6	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2020 - 02/2003
6	MucinsIBA 03/2019 - 11/2013
6	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 11/2008
6	ChemokinesIBA 01/2019 - 10/2009
6	CarcinogensIBA 11/2018 - 02/2003
6	Presenilin-2IBA 01/2017 - 09/2005
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2014 - 10/2005
6	Melitten (Melittin)IBA 01/2012 - 11/2004
5	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2022 - 08/2015
5	Messenger RNA (mRNA)IBA 07/2021 - 09/2014
5	astaxanthine (astaxanthin)IBA 03/2020 - 01/2018
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 04/2014
5	Melanocyte-Stimulating Hormones (MSH)IBA 01/2019 - 06/2013
5	FlavonoidsIBA 05/2017 - 07/2012
5	Cisplatin (Platino)FDA LinkGeneric 01/2015 - 05/2009
5	TeaIBA 07/2013 - 10/2005
4	Phosphotransferases (Kinase)IBA 01/2022 - 12/2009
4	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 04/2016
4	Interleukin-6 (Interleukin 6)IBA 07/2021 - 02/2015
4	Tannic Acid FDA Link 01/2021 - 01/2016
4	Galla RhoisIBA 01/2021 - 01/2016
4	Cholinergic Agents (Cholinergics)IBA 01/2021 - 10/2018
4	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2021 - 04/2014
4	LeptinIBA 12/2020 - 03/2015
4	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020 - 04/2008
4	Advanced Glycation End ProductsIBA 11/2019 - 10/2011
4	Urethane (Ethyl Carbamate)IBA 06/2019 - 12/2012
4	PresenilinsIBA 06/2019 - 09/2005
4	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 02/2019 - 05/2012
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 01/2007
4	Glucose (Dextrose)FDA LinkGeneric 09/2018 - 09/2012
4	Hormones (Hormone)IBA 12/2017 - 02/2007

Therapy/Procedure

17	Therapeutics 01/2022 - 08/2007
8	Immunotherapy 02/2019 - 07/2010
5	Aftercare (After-Treatment) 10/2018 - 11/2013
5	Traditional Medicine (Folk Remedies) 11/2017 - 08/2007
4	Drug Therapy (Chemotherapy) 01/2021 - 05/2009